bf/NASDAQ:SRPT_icon.jpeg

NASDAQ:SRPT

Sarepta Therapeutics, Inc.

  • Stock

USD

Last Close

132.74

17/05 20:00

Market Cap

11.11B

Beta: 1.02

Volume Today

848.47K

Avg: 1.51M

PE Ratio

−16.13

PFCF: −19.07

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
14.22M
-
9.76M
31.38%
1.25M
87.16%
5.42M
332.64%
154.58M
2,751.58%
301.03M
94.74%
380.83M
26.51%
540.10M
41.82%
701.89M
29.96%
933.01M
32.93%
1.24B
33.26%
cost of revenue
90.28M
-
130K
-
7.35M
5,556.15%
34.19M
365.02%
56.59M
65.49%
63.38M
12.01%
97.05M
53.12%
139.99M
44.25%
150.34M
7.40%
gross profit
-76.06M
-
9.76M
112.83%
1.25M
87.16%
5.29M
322.27%
147.23M
2,682.67%
266.84M
81.24%
324.25M
21.51%
476.72M
47.02%
604.84M
26.88%
793.02M
31.11%
1.09B
37.83%
selling and marketing expenses
2.55M
-
2.83M
11.15%
-2.22M
178.46%
general and administrative expenses
31.59M
-
49.31M
56.09%
75.04M
52.17%
81.20M
8.21%
119.85M
47.60%
209.98M
75.20%
284.81M
35.64%
317.88M
11.61%
282.66M
11.08%
451.42M
59.70%
481.87M
6.75%
selling general and administrative expenses
31.59M
-
49.31M
56.09%
75.04M
52.17%
83.75M
11.60%
122.68M
46.49%
207.76M
69.35%
284.81M
37.09%
317.88M
11.61%
282.66M
11.08%
451.42M
59.70%
481.87M
6.75%
research and development expenses
72.91M
-
94.23M
29.24%
146.39M
55.36%
188.27M
28.61%
166.71M
11.45%
401.84M
141.05%
560.91M
39.58%
722.34M
28.78%
771.18M
6.76%
877.09M
13.73%
877.39M
0.03%
other expenses
1.98M
-
-656K
133.10%
849K
229.42%
662K
22.03%
706K
6.65%
714K
1.13%
1.56M
118.35%
cost and expenses
104.50M
-
143.55M
37.36%
221.44M
54.26%
272.15M
22.90%
297.80M
9.42%
644.66M
116.48%
903.16M
40.10%
1.10B
22.27%
1.15B
4.29%
1.47B
27.58%
1.51B
2.85%
operating expenses
104.50M
-
143.55M
37.36%
221.44M
54.26%
272.02M
22.84%
290.44M
6.77%
610.47M
110.19%
846.57M
38.68%
1.04B
22.95%
1.05B
1.31%
1.33B
26.05%
1.36B
2.38%
interest expense
326K
-
-535K
-
5.78M
1,180.56%
33.71M
483.10%
30.67M
9.02%
59.95M
95.46%
63.52M
5.97%
53.25M
16.18%
22.01M
58.67%
ebitda
-68.26M
-
-131.01M
91.94%
-220.18M
68.07%
-266.73M
21.14%
-238.73M
10.50%
-342.76M
43.58%
-469.42M
36.95%
-529.28M
12.75%
-412.12M
22.14%
-473.54M
14.90%
-267.82M
43.44%
operating income
-90.28M
-
-133.79M
48.19%
-220.18M
64.58%
-266.73M
21.14%
-171.64M
35.65%
-343.63M
100.21%
-522.32M
52.00%
-564.16M
8.01%
-449.71M
20.29%
-536.20M
19.23%
-267.82M
50.05%
depreciation and amortization
1.28M
-
3.69M
188.96%
5.25M
42.20%
5.61M
6.94%
1.05M
81.23%
865K
17.85%
52.90M
6,015.49%
34.89M
34.05%
37.59M
7.75%
62.67M
66.70%
58.89M
6.02%
total other income expenses net
-22.03M
-
-2.78M
87.38%
154K
105.54%
-2.55M
1,754.55%
96.57M
3,890.15%
10.14M
89.50%
-191.56M
1,989.31%
11.10M
105.79%
30.76M
177.19%
-153.76M
599.84%
-252.27M
64.07%
income before tax
-111.98M
-
-135.79M
21.26%
-220.03M
62.04%
-267.26M
21.47%
-48.63M
81.81%
-362.61M
645.68%
-713.88M
96.87%
-553.07M
22.53%
-418.95M
24.25%
-689.96M
64.69%
-520.10M
24.62%
income tax expense
20.42M
-
-1.69M
108.27%
-5.25M
210.47%
-7.62M
45.30%
2.06M
127.02%
-692K
133.59%
1.20M
272.69%
1.06M
11.05%
-168K
115.80%
13.53M
8,150.60%
15.88M
17.40%
net income
-111.98M
-
-135.79M
21.26%
-220.03M
62.04%
-267.26M
21.47%
-50.69M
81.03%
-361.92M
614.01%
-715.08M
97.58%
-554.13M
22.51%
-418.78M
24.43%
-703.49M
67.99%
-535.98M
23.81%
weighted average shs out
33.83M
-
40.03M
18.31%
42.29M
5.66%
48.68M
15.12%
58.82M
20.82%
66.25M
12.64%
73.61M
11.12%
77.96M
5.90%
81.26M
4.24%
87.56M
7.75%
92.40M
5.53%
weighted average shs out dil
33.85M
-
40.03M
18.25%
42.29M
5.66%
48.70M
15.15%
58.82M
20.78%
66.25M
12.64%
73.61M
11.12%
77.96M
5.90%
81.26M
4.24%
87.56M
7.75%
92.40M
5.53%
eps
-3.31
-
-3.39
2.42%
-5.20
53.39%
-5.49
5.58%
-0.86
84.34%
-5.46
534.88%
-9.71
77.84%
-7.11
26.78%
-5.15
27.57%
-8.03
55.92%
-5.80
27.77%
epsdiluted
-3.31
-
-3.39
2.42%
-5.20
53.39%
-5.49
5.58%
-0.86
84.34%
-5.46
534.88%
-9.71
77.84%
-7.11
26.78%
-5.15
27.57%
-8.03
55.92%
-5.80
27.77%

All numbers in USD (except ratios and percentages)